Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects.

Green A, Kaul A, O'Shea J, Sharma E, Bennett L, Mullings EL, Munafò MR, Nutt DJ, Melichar JK, Donaldson LF.

J Psychopharmacol. 2013 Mar;27(3):265-75. doi: 10.1177/0269881112472567.

PMID:
23364815
2.

Maintenance medication for opiate addiction: the foundation of recovery.

Bart G.

J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598. Review.

3.

Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.

Curr Drug Abuse Rev. 2012 Mar;5(1):52-63. Review.

4.

Heroin anticraving medications: a systematic review.

Fareed A, Vayalapalli S, Casarella J, Amar R, Drexler K.

Am J Drug Alcohol Abuse. 2010 Nov;36(6):332-41. doi: 10.3109/00952990.2010.505991. Review.

PMID:
20955107
5.
6.

Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.

Yee A, Loh HS, Hisham Hashim HM, Ng CG.

Int J Impot Res. 2014 Sep-Oct;26(5):161-6. doi: 10.1038/ijir.2014.18. Review.

PMID:
24990199
7.

Opioid agonist treatment for pharmaceutical opioid dependent people.

Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N.

Cochrane Database Syst Rev. 2016 May 9;(5):CD011117. doi: 10.1002/14651858.CD011117.pub2. Review.

PMID:
27157143
8.

[Analgesic management of acute pain in patients receiving methadone or buprenorphine].

Zinck L, Sonne NM, Madsen SL, Nikolajsen L.

Ugeskr Laeger. 2015 Mar 2;177(10). pii: V10140557. Review. Danish.

PMID:
25749118
9.

Long-term course of opioid addiction.

Hser YI, Evans E, Grella C, Ling W, Anglin D.

Harv Rev Psychiatry. 2015 Mar-Apr;23(2):76-89. doi: 10.1097/HRP.0000000000000052. Review.

PMID:
25747921
10.

Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.

Connery HS.

Harv Rev Psychiatry. 2015 Mar-Apr;23(2):63-75. doi: 10.1097/HRP.0000000000000075. Review.

PMID:
25747920
11.

Therapies in early development for the treatment of opiate addiction.

Rodríguez-Arias M, Aguilar MA, Miñarro J.

Expert Opin Investig Drugs. 2015;24(11):1459-72. doi: 10.1517/13543784.2015.1086746. Review.

PMID:
26414784
12.

[Limited role of naltrexone in the treatment of opiate addiction].

van Brussel GH.

Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1452-6. Review. Dutch.

PMID:
11503313
13.

Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available.

Krupitsky E, Zvartau E, Woody G.

Curr Psychiatry Rep. 2010 Oct;12(5):448-53. doi: 10.1007/s11920-010-0135-5. Review.

14.

Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.

Cottrill CB, Matson SC.

Adolesc Med State Art Rev. 2014 Aug;25(2):251-65. Review. No abstract available.

PMID:
27132312
15.

Buprenorphine and methadone for opioid addiction during pregnancy.

Mozurkewich EL, Rayburn WF.

Obstet Gynecol Clin North Am. 2014 Jun;41(2):241-53. doi: 10.1016/j.ogc.2014.02.005. Review.

PMID:
24845488
16.

The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study.

Yee A, Loh HS, Hisham Hashim HM, Ng CG.

J Sex Med. 2014 Jan;11(1):22-32. doi: 10.1111/jsm.12352. Review.

PMID:
24344738
17.

Retention in medication-assisted treatment for opiate dependence: A systematic review.

Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C.

J Addict Dis. 2016;35(1):22-35. doi: 10.1080/10550887.2016.1100960. Review.

PMID:
26467975
18.

Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.

Alford DP, Compton P, Samet JH.

Ann Intern Med. 2006 Jan 17;144(2):127-34. Review. Erratum in: Ann Intern Med. 2006 Mar 21;144(6):460.

19.

Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.

Tetrault JM, Fiellin DA.

Drugs. 2012 Jan 22;72(2):217-28. doi: 10.2165/11597520-000000000-00000. Review.

20.

Monitoring Intravenous Abuse of Methadone or Buprenorphine in Opiate Maintenance Treatment (OMT): A Simple and Fast LC-MS-MS Method for the Detection of Disaccharides in Urine Samples.

Jungen H, Andresen-Streichert H, Müller A, Iwersen-Bergmann S.

J Anal Toxicol. 2017 Jan;41(1):22-31. doi: 10.1093/jat/bkw099. Review.

PMID:
28130543
Items per page

Supplemental Content

Support Center